Skip to main content
Caplight Logo









SeekIn Inc.

SeekIn Inc.

Private
ShenzhenHealthcare & Life Scienceshttps://www.seekincancer.com/

Last Round

Strategic

Dec 13, 2021

Momentum

Top 10%

of companies Caplight tracks

Company Overview

SeekIn Inc. is a biotechnology company that develops blood-based pan-cancer early detection and monitoring solutions utilizing next-generation sequencing and artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

multi-cancer early detectionMCEDliquid biopsycancer screeningnext-generation sequencingNGScell-free DNAcfDNAmedical AIprecision medicinecancer diagnosticstumor markersAI-driven diagnosticsmulti-omicsclinical decision support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SeekIn Inc. Comparables

Compare SeekIn Inc. with similar companies based on industry and business-model similarity.

SeekIn Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Singlera Genomics Inc.
82%
AcornMed Biotechnology Co., Ltd.
82%
Lucence
78%

SeekIn Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicDec 13, 2021
Series AMay 1, 2020
VC RoundMay 1, 2019
AngelJun 1, 2018

Key People

Founding team and executive leadership

Shujia Hao

Co-founder & Chief Financial Officer

Founding Team

MAO MAO

Founder & CEO

Founding Team

SeekIn Inc. Investors

Notable investors and investment history

SeekIn Inc. investors
InvestorRounds
Shanda CapitalStrategic
Qingcheng CapitalVC Round
松禾资本 (Green Pine Capital Partners)Angel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 53% MoM.

  • May 20, 2026

    Monthly visitors increased 42% MoM.

SeekIn Inc. Filings

Explore SEC and related filing metadata, where available.

SeekIn Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SeekIn Inc.'s valuation, stock price, and market status.

Is SeekIn Inc. a public or private company?

SeekIn Inc. is a private company.

What is the current stock price of SeekIn Inc.?

SeekIn Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is SeekIn Inc. worth (valuation)?

Valuation information for SeekIn Inc. is not publicly available.

Can I buy SeekIn Inc. stock?

SeekIn Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SeekIn Inc.'s last funding round?

SeekIn Inc.'s most recent funding round was Strategic on December 13, 2021.

Who are the main investors in SeekIn Inc.?

Key investors in SeekIn Inc. include Shanda Capital, Qingcheng Capital, 松禾资本 (Green Pine Capital Partners).

Will SeekIn Inc. IPO soon?

No public IPO plans have been announced for SeekIn Inc..

How can I track SeekIn Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SeekIn Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersShenzhen
Employee Range7
Year Founded2018
Last FundingDec 13, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?